STAT+: Eli Lilly warns hospitals to submit claims data in the next five days or lose their 340B drug discounts

AI justification

Enforcement action risks harming healthcare access despite program integrity goals. | While Eli Lilly's enforcement of the 340B program aims to ensure compliance and transparency, the short deadline and potential loss of drug discounts for non-compliant hospitals risk undermining healthcare access for low-income patients. The action balances program integrity with the risk of unintended harm to vulnerable populations.